Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Up 216.6% in May

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the target of a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 120,253 shares, an increase of 216.6% from the April 30th total of 37,978 shares. Based on an average daily trading volume, of 38,663 shares, the short-interest ratio is currently 3.1 days.

Conduit Pharmaceuticals Price Performance

Conduit Pharmaceuticals stock traded up $0.00 during midday trading on Friday, reaching $0.01. The stock had a trading volume of 71,776 shares, compared to its average volume of 26,793. The stock’s 50-day simple moving average is $0.01 and its 200 day simple moving average is $0.01. Conduit Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.02.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.